Zenotech Laboratories Limited Share Price

Equities

ZENOTECH6

INE486F01012

Pharmaceuticals

Market Closed - Bombay S.E. 03:30:56 31/05/2024 pm IST 5-day change 1st Jan Change
59.42 INR -2.40% Intraday chart for Zenotech Laboratories Limited -2.83% -10.75%
Sales 2022 33Cr 39.5L Sales 2023 39Cr 46.77L Capitalization 287.21Cr 3.44Cr
Net income 2022 22Cr 26.62L Net income 2023 12Cr 13.91L EV / Sales 2022 9.44 x
Net Debt 2022 3.59Cr 4L Net cash position 2023 11Cr 13.36L EV / Sales 2023 7.08 x
P/E ratio 2022
13.9 x
P/E ratio 2023
24.8 x
Employees 150
Yield 2022 *
-
Yield 2023
-
Free-Float 15.21%
More Fundamentals * Assessed data
Dynamic Chart
Zenotech Laboratories Limited Announces Resignation of Devendra Chandrakant Shenvi Kenkre as Chief Executive Officer, Effective August 12, 2024 CI
Zenotech Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Zenotech Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022 CI
Sun Pharmaceutical Acquires More Stake in Zenotech Laboratories MT
Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
More news
1 day-2.40%
1 week-2.83%
1 month-9.86%
3 months-13.56%
6 months-10.57%
Current year-10.75%
More quotes
1 week
58.01
Extreme 58.01
62.00
1 month
58.01
Extreme 58.01
66.00
Current year
55.86
Extreme 55.86
81.00
1 year
49.60
Extreme 49.6
81.00
3 years
38.00
Extreme 38
81.00
5 years
12.00
Extreme 12
81.00
10 years
12.00
Extreme 12
81.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23/21/23
Director of Finance/CFO - 06/14/06
Compliance Officer - 11/16/11
Members of the board TitleAgeSince
Director/Board Member 56 01/15/01
Director/Board Member 56 08/15/08
Chairman 65 25/15/25
More insiders
Date Price Change Volume
31/24/31 59.42 -2.40% 9,709
30/24/30 60.88 -0.73% 17,335
29/24/29 61.33 +0.15% 8,206
28/24/28 61.24 -0.78% 26,403
27/24/27 61.72 +0.93% 12,414

Delayed Quote Bombay S.E., May 31, 2024 at 03:30 pm IST

More quotes
Zenotech Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in a business of manufacture and marketing of pharmaceuticals products. The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing oncology, biotechnology and general injectables products. The Company has a manufacturing facility at Turkapally village, Shamirpet Mandal, Telangana.
More about the company
  1. Stock Market
  2. Equities
  3. ZENOTECH6 Stock